Clinical trial
Lurasidone Effects on Tissue Glutamate in Schizophrenia
NCT02199743
Study timeline
Study start (unknown)2013-02-01Date precision: month
Registry last updated2021-03-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
LurasidoneDRUG · verified · RxNorm: lurasidone
HaloperidolDRUG · verified · RxNorm: haloperidol
PerphenazineDRUG · verified · RxNorm: perphenazine
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
Sumitomo Pharma America, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02199743 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.